On January 9, 2026, the latest edition of Applied Artificial Intelligence for Drug Discovery was published online as a Springer Nature volume, spanning 27 chapters authored by leading international experts to present state-of-the-art approaches in the whole drug discovery process. As a pioneering global biotechnology company, Insilico Medicine (3696.HK) made exclusive contributions to two chapters in the comprehensive and forward-looking volume, sharing experience in real-life application of AI in early drug target-related tasks including evaluation, and giving prospects for the future assisted with quantum computing. The book has obtained 1700+ accesses, only 10 days after publication.

Researchers have mapped the cellular diversity of the eye’s fluid drainage tissue, identifying a cell subtype that shows early signs of dysfunction in a genetic mouse model of glaucoma. Their study, published today in eLife as the final Version of Record after appearing previously as a Reviewed Preprint, provides what the editors say are fundamental findings, highlighting vitamin B3 treatment as a potential therapeutic strategy for preventing or slowing the development of glaucoma.